ログイン

BLOOD BANKING PROGRESS EXAM

BLOOD BANKING PROGRESS EXAM
100問 • 1年前
  • Yves Laure Pimentel
  • 通報

    問題一覧

  • 1

    Transfusion-transmissible infectious agents for which UNIVERSAL SCREENING of all donations in all countries is recommended. Check four (4) boxes.

    Human immunodeficiency virus (HIV), Hepatitis B virus (HBV), Hepatitis C virus (HCV), Treponema pallidum (syphilis)

  • 2

    What is the maximum volume of blood that can be collected from a 110-lb donor, including samples for processing? * 0/1 450 mL 500 mL 525 mL 550 mL

    525 mL

  • 3

    When RBCs are stored, there is a “shift to the left.” This means: * 1/1 Hemoglobin-oxygen affinity increases, owing to an increase in 2,3 -DPG Hemoglobin-oxygen affinity increases, owing to a decrease in 2,3-DPG Hemoglobin-oxygen affinity decreases, owing to a decrease in 2,3-DPG Hemoglobin-oxygen affinity decreases, owing to an increase in 2,3-DPG

    Hemoglobin-oxygen affinity increases, owing to a decrease in 2,3-DPG

  • 4

    What are the current storage time and storage temperature for platelet concentrates and apheresis platelet components? * 1/1 5 days at 1°C to 6°C 5 days at 24°C to 27°C 5 days at 20°C to 24°C 7 days at 22°C to 24°C

    5 days at 20°C to 24°C

  • 5

    Prestorage pooled platelets can be stored for: * 0/1 4 hours 24 hours 5 days 7 days

    5 days

  • 6

    Additive solutions are approved for storage of red blood cells for how many days? * 0/1 21 42 35 7

    42

  • 7

    One criterion used by the FDA for approval of new preservation solutions and storage containers is an average 24-hour post-transfusion RBC survival of more than: * 1/1 50% 60% 65% 75%

    75%

  • 8

    What is the lowest allowable pH for a platelet component at outdate? * 1/1 6 5.9 6.8 6.2

    6.2

  • 9

    Which of the following occurs during storage of red blood cells? * 0/1 pH decreases 2,3-DPG increases ATP increases Plasma K+ decreases

    pH decreases

  • 10

    Which of the following is approved for bacterial detection specific to extending the expiration of apheresed platelets to 7 days? * 1/1 BacT/ALERT eBDS Gram stain Pan Genera Detection (PGD) test

    Pan Genera Detection (PGD) test

  • 11

    The pattern of inheritance most commonly expressed by blood group genes is: * 1/1 X-linked recessive Autosomal recessive Autosomal codominant X-linked codominant

    Autosomal codominant

  • 12

    RBCs must be washed in saline at least three times before the addition of AHG reagent to: * 0/1 Wash away any hemolyzed cells Remove traces of free serum globulins Neutralize any excess AHG reagent Increase the antibody binding to antigen

    Remove traces of free serum globulins

  • 13

    You are working on a specimen in the laboratory that you believe to be a Bombay phenotype. Which of the following reactions would you expect to see? * 0/1 Patient’s cells + Ulex europaeus = no agglutination Patient’s cells + Ulex europaeus = agglutination Patient’s serum + group O donor RBCs = no agglutination Patient’s serum + A1 and B cells = no agglutination

    Patient’s cells + Ulex europaeus = no agglutination

  • 14

    Which of the following ABO blood groups contains the least amount of H substance? * 1/1 A1B A2 B O

    A1B

  • 15

    Cells carrying a weak D antigen require the use of what test to demonstrate its presence? * 0/1 Indirect antiglobulin test Direct antiglobulin test Microplate test Warm autoadsorption test

    Indirect antiglobulin test

  • 16

    Which of the following is the most common haplotype in the African American population? * 1/1 DCe DcE Dce ce

    Dce

  • 17

    If a patient who is R1R1 is transfused with RBCs that are R0r, which antibody is he most likely to produce? * 0/1 Anti-D Anti-c Anti-e Anti-G

    Anti-c

  • 18

    The following results were obtained on a 51-year-old male with hepatitis C: * 0/1 Retype the patient’s sample to confirm group AB positive Repeat the Rh typing Run a saline control in forward grouping Report the patient as group AB, Rh positive

    Run a saline control in forward grouping

  • 19

    What is the purpose of including a reagent control when interpreting group AB, D-positive red cells after testing with a low-protein anti-D reagent? * 0/1 To detect false-positive agglutination reactions To detect false-negative agglutination reactions To identify a mix up with patient’s sample To confirm ABO typing results

    To detect false-positive agglutination reactions

  • 20

    Transformation to Leb phenotype after birth may be as follows: * 1/1 Le(a–b–) to Le(a+b–) to Le(a+b+) to Le(a–b+) Le(a+b–) to Le(a–b–) to Le(a–b+) to Le(a+b+) Le(a–b+) to Le(a+b–) to Le(a+b+) to Le(a–b–) Le(a+b+) to Le(a+b–) to Le(a–b–) to Le(a–b+)

    Le(a–b–) to Le(a+b–) to Le(a+b+) to Le(a–b+)

  • 21

    In what way do the Lewis antigens change during pregnancy? * 0/1 Lea antigen increases only Leb antigen increases only Lea and Leb both increase Lea and Leb both decrease

    Lea and Leb both decrease

  • 22

    The most commonly encountered of the Lewis antibodies: * 0/1 Anti-Le a Anti-Le b Anti-Le bH Anti-Le bL

    Anti-Le a

  • 23

    Which of the following best describes MN antigens and antibodies? * 1/1 Well developed at birth, susceptible to enzymes, generally saline reactive Not well developed at birth, susceptible to enzymes, generally saline reactive Well developed at birth, not susceptible to enzymes, generally saline reactive Well developed at birth, susceptible to enzymes, generally antiglobulin reactive

    Well developed at birth, susceptible to enzymes, generally saline reactive

  • 24

    Which autoantibody specificity is found in patients with paroxysmal cold hemoglobinuria? * 1/1 Anti-I Anti-i Anti-P Anti-P1

    Anti-P

  • 25

    Which of the following is the most common antibody seen in the blood bank after ABO and Rh antibodies? * 0/1 Anti-Fya Anti-k Anti-Jsa Anti-K

    Anti-K

  • 26

    Which antibody is most commonly associated with delayed hemolytic transfusion reactions? * 1/1 Anti-s Anti-k Anti-Lu Anti-Jk

    Anti-Jk

  • 27

    A patient with an M. pneumoniae infection will most likely develop a cold autoantibody with specificity to which antigen? * 0/1 I i P P1

    I

  • 28

    The antibody to this high-prevalence antigen demonstrates mixed-field agglutination that appears shiny and refractile under the microscope. * 0/1 Vel JMH Jr Sd

    Sd

  • 29

    What red blood cell treatment can be used to differentiate between anti-D and anti-LW? * 0/1 Ficin Trypsin Dithiothreitol (DTT) Papain

    Dithiothreitol (DTT)

  • 30

    A weakly reactive antibody with a titer of 128 is neutralized by plasma. Which of the following could be the specificity? * 1/1 Anti-JMH Anti-Ch Anti-Kn Anti-Kp

    Anti-Ch

  • 31

    The prevalence of ____ in Northern Europeans is 1% but is higher in the Mennonite population * 1/1 Diego a Diego b Scianna 1 Scianna 2

    Scianna 2

  • 32

    Anti-Sda has been identified in a patient. What substance would neutralize this antibody and allow detection of other alloantibodies? * 0/1 Saliva Hydatid cyst fluid Urine Human breast milk

    Urine

  • 33

    How many days before a pretransfusion specimen expires? * 1/1 3 days 7 days 14 days 1 month

    3 days

  • 34

    How many days must a pretransfusion specimen and donor unit segments be retained post-transfusion? * 0/1 3 days 7 days 14 days 1 month

    7 days

  • 35

    Which is not true of rouleaux formation? * 1/1 Mimics agglutination Appears like a “stacking of coins” Can be seen in the antiglobulin test Can be dispersed by saline

    Can be seen in the antiglobulin test

  • 36

    Protein A captures antibodies by binding to the: * 1/1 Fab portion of immunoglobulin Fc portion of immunoglobulin Surface of test cells Surface of indicator cells

    Fc portion of immunoglobulin

  • 37

    Immunization for rubella (German measles) would result in a temporary deferral for: * 1/1 4 weeks 2 weeks 1 year 3 years

    4 weeks

  • 38

    Which of the following carries a 12-month deferral? * 1/1 Donor received Hepatitis B immune globulin Donor received pituitary growth hormone from another human Donor received the MMR vaccine Donor spent 10 years in Africa

    Donor received Hepatitis B immune globulin

  • 39

    A first-trimester or second trimester abortion or miscarriage: * 1/1 4 weeks deferral 6 weeks deferral 12 months deferral Not cause for deferral

    Not cause for deferral

  • 40

    Donors who have received a transfusion of blood or its components or other human tissues (organ, tissue, bone marrow transplant, or bone or skin graft) known to be possible sources of bloodborne pathogens should be deferred for _____ from the time of receiving the blood product or graft * 0/1 4 weeks 6 weeks 12 months 3 years

    12 months

  • 41

    Currently, steps taken to reduce transfusion-transmitted CMV include: * 1/1 Plaque reduction neutralization test NAT testing Leukoreduction Minipool screening

    Leukoreduction

  • 42

    The first retrovirus to be associated with human disease was: * 1/1 HCV HIV-1 HTLV-1 WNV

    HTLV-1

  • 43

    What is the most common parasitic complication of transfusion? * 1/1 Babesia microti Trypanosoma cruzi Plasmodium species Toxoplasma gondii

    Plasmodium species

  • 44

    RBCs that have been leukoreduced must contain less than ______ leukocytes and retain at least ______ of original RBCs. * 1/1 8 × 10 6th/ 85% 8 × 10 6th/ 90% 5 × 10 6th/ 85% 5 × 10 6th / 80%

    5 × 10 6th/ 85%

  • 45

    Patient with APLASTIC ANEMIA should be transfused with: * 0/1 Fresh whole blood (FWB) Washed RBCs less than 7 days old Fresh frozen plasma and platelets Cryoprecipitated AHF

    Washed RBCs less than 7 days old

  • 46

    Leukocyte-reduced filters can do all of the following except: * 1/1 Reduce the risk of CMV infection Prevent or reduce the risk of HLA alloimmunization Prevent febrile, nonhemolytic transfusion reactions Prevent TA-GVHD

    Prevent TA-GVHD

  • 47

    Which patient does NOT need an irradiated component? * 0/1 Bone marrow transplant recipient Neonate weighing less than 1,200 g Adult receiving an RBC transfusion Adult receiving an RBC transfusion from a blood relative

    Adult receiving an RBC transfusion

  • 48

    RBC transfusions should be given: * 1/1 Within 4 hours With lactated Ringer solution With dextrose and water With cryoprecipitate

    Within 4 hours

  • 49

    Which type of transplantation requires all cellular blood components to be irradiated? * 1/1 Bone marrow Heart Liver Kidney

    Bone marrow

  • 50

    Select the appropriate product for a bone marrow transplant patient with anemia: * 1/1 RBCs Irradiated RBCs Leukoreduced RBCs Washed RBCs

    Irradiated RBCs

  • 51

    Which fluid should be used to dilute RBCs? * 0/1 0.9% saline 5% dextrose and water Immune globulin Lactated Ringer solution

    0.9% saline

  • 52

    Fatal transfusion reactions are mostly caused by: * 1/1 Serologic errors Improper storage of blood Improper handling of the product Clerical errors

    Clerical errors

  • 53

    Pain at infusion site and hypotension are observed with what type of reaction? * 0/1 Delayed hemolytic transfusion reaction Acute hemolytic transfusion reaction Allergic reaction Febrile nonhemolytic reaction

    Acute hemolytic transfusion reaction

  • 54

    The most common isolate found in RBC units: * 1/1 Bacillus cereus Propionobacterium acnes Staphylococcus epidermidis Yersinia enterocolitica

    Yersinia enterocolitica

  • 55

    The organisms most frequently recovered from donated blood and contamination of platelets: * 0/1 Yersinia enterocolitica and Pseudomonas species Yersinia enterocolitica and Propionobacterium acnes Staphylococcus aureus and Bacillus cereus Staphylococcus epidermidis and Bacilus cereus

    Staphylococcus epidermidis and Bacilus cereus

  • 56

    The only presenting sign most often accompanying a delayed hemolytic transfusion reaction is: * 0/2 Renal failure Unexplained decrease in hemoglobin Active bleeding Hives

    Unexplained decrease in hemoglobin

  • 57

    Which transfusion reaction presents with fever, maculopapular rash, watery diarrhea, abnormal liver function, and pancytopenia? * 1/1 Transfusion-associated sepsis Transfusion-related acute lung injury Transfusion-associated graft-versus-host disease Transfusion-associated allergic reaction

    Transfusion-associated graft-versus-host disease

  • 58

    The most common anticoagulant used for apheresis procedures is: * 0/1 Heparin Sodium fluoride Warfarin Citrate

    Citrate

  • 59

    The minimum interval allowed between plateletpheresis component collection procedures is: * 1/1 1 day 2 days 7 days 8 weeks

    2 days

  • 60

    Which of the following can be given to an apheresis donor to increase the number of circulating granulocytes? * 1/1 DDAVP Hydroxyethyl starch (HES) Immune globulin G-CSF

    G-CSF

  • 61

    Acute transfusion reactions: signs or symptoms presenting during or within ___ hours of transfusion * 0/1 Within 4 hours Within 24 hours Within 48 hours Within 72 hours

    Within 24 hours

  • 62

    In humans, there are ____ chromosomes. * 1/1 2 chromosomes (1 pair) 22 chromosomes (11 pairs) 44 chromosomes (22 pairs) 46 chromosomes (23 pairs)

    46 chromosomes (23 pairs)

  • 63

    Humans have ___ autosomes and ____ of sex chromosomes, * 0/1 1 pair of autosomes, 23 pairs sex chromosomes 22 pairs of autosomes, 2 pairs sex chromosomes 22 pairs of autosomes, 1 pair sex chromosomes 23 pairs of autosomes, 1 pair sex chromosomes

    22 pairs of autosomes, 1 pair sex chromosomes

  • 64

    A1 individuals: * 0/1 A antigen A and A1 antigens Anti-A2 Production of only 240,000 to 290,000 antigen sites on the adult RBCs

    A and A1 antigens

  • 65

    The ultimate goal of biological safety is to: * 0/1 Provide safe and sterile working area Provide immunity to healthcare workers Prevent completion of the chain of infection by preventing transmission Prevent the spread of harmful aerosols

    Prevent completion of the chain of infection by preventing transmission

  • 66

    Which of the following includes an amorph? * 1/1 DcE DCE dce All of these

    dce

  • 67

    A cause of indefinite deferral of blood donation is: * 1/1 German measles vaccination Residence in an endemic malaria region Positive test for Trypanosoma cruzi History of therapeutic rabies vaccine

    Positive test for Trypanosoma cruzi

  • 68

    Which one of the following constitutes permanent deferral status of a donor? * 1/1 Tattoo 5 months previously Recent close contact with a patient with viral hepatitis 2 units of blood transfused 4 months previously Confirmed positive test for HBsAg 10 years previously

    Confirmed positive test for HBsAg 10 years previously

  • 69

    Which of the following donors may be accepted as a blood donor? * 0/1 Traveled to an area endemic for malaria 9 months previously Spontaneous abortion at 2 months, 3 months previously Resides with a known hepatitis B patient Received blood transfusion 22 weeks previously

    Spontaneous abortion at 2 months, 3 months previously

  • 70

    In order to be a plateletpheresies donor, the platelet count must be at least: * 1/1 150,000/uL 200,000/uL 250,000/uL 300,000/uL

    150,000/uL

  • 71

    Prior to blood donation, the intended venipuncture site must be cleaned with a scrub solution containing: * 1/1 Hypochlorite Green soap 10% acetone Povidone iodine

    Povidone iodine

  • 72

    What is/are the minimum pretransfusion testing requirement(s) for autologous donations collected and transfused by the same facility? * 0/1 ABO and Rh typing only ABO/Rh type and antibody screen ABO/Rh type, antibody screen, crossmatch No pretransfusion testing is required for autologous donation

    ABO and Rh typing only

  • 73

    Upon inspection, a unit of aphaeresis platelets is noted to have visible clots, but otherwise appears normal. The technologist should: 1/1 Issue without concern Filter to remove clots Centrifuge to express off the clots Quarantine for Gram stain and culture

    Quarantine for Gram stain and culture

  • 74

    An important determinant of platelet viability during storage is: * 1/1 Plasma potassium concentration Plasma pH Prothrombin time Partial thromboplastin time Feedback

    Plasma pH

  • 75

    term refers to the test results obtained with specific antisera,

    PHENOTYPE

  • 76

    refers to the genetic makeup of an individual.

    GENOTYPE

  • 77

    An individual's red blood cells give the following reactions with RH antisera: anti-D (4+), anti-C (3+), anti-E (neg), anti-c(3+) anti-e (3+). The individual's most probable GENOTYPE is: * 0/1 DCe/DcE DcE/dce Dce/dce DCe/dce

    DCe/dce

  • 78

    An individual's red blood cells give the following reactions with RH antisera: anti-D (4+), anti-C (3+), anti-E (neg), anti-c(3+) anti-e (3+). The individual's PHENOTYPE is: * 0/1 Dce/dce DCe/dce DCce Dce

    DCce

  • 79

    ABO hemolytic disease of the fetus and newborn (HDFN) differs from Rh HDFN in that: * 0/1 Rh HDFN is clinically more severe than ABO HDFN The direct antiglobulin test is weaker in Rh HDFN than ABO Rh HDFN occurs in the first pregnancy The mother's antibody screen is positive in ABO HDFN

    Rh HDFN is clinically more severe than ABO HDFN

  • 80

    RBCs agglutinated by Dolichos biflorus: * 1/1 O red cells B and AB red cells A2 and A2B red cells A1 and A1B red cells

    A1 and A1B red cells

  • 81

    Some blood group antibodies characteristically hemolyze appropriate antigen-positive red cells in the presence of : * 1/1 Complement Anticoagulants Preservatives Penicillin

    Complement

  • 82

    The major crossmatch will detect a(an): * 1/1 Group A patient mistyped as O Unexpected red cell antibody in the donor unit Rh-negative donor unit mislabeled as Rh-positive Recipient antibody directed against antigens on the donor red cells

    Recipient antibody directed against antigens on the donor red cells

  • 83

    In the Fisher-Race nomenclature, "d" represents: * 1/1 Presence of D antigen Absence of D antigen Elimination of D antigen Weak D antigen

    Absence of D antigen

  • 84

    If the Du rosette test is positive, quantitation of the fetomaternal hemorrhage must be done by: * 0/1 Spectrophotometric technique Indirect antiglobulin test Flow cytometry Hemagglutination-inhibition test

    Flow cytometry

  • 85

    Performed as early as 10 to 12 weeks’ gestation to determine whether the FETUS has the gene for the D antigen: * 1/1 Amniocentesis Cordocentesis Peripheral blood sample None of these

    Amniocentesis

  • 86

    Defined as the proportion of cases with a specific disease or condition that give a positive test result: * 0/1 Sensitivity Specificity

    Sensitivity

  • 87

    Defined as the proportion of cases with absence of the specific disease or condition that gives a negative test result: * 0/1 Sensitivity Specificity

    Specificity

  • 88

    How are Rh antigens inherited? * 1/1 Autosomal recessive alleles Sex-linked genes Codominant alleles X-linked

    Codominant alleles

  • 89

    Which animal was immunized that led to discovery of the Rh blood group? * 0/1 Mice Bats Guinea pigs and rabbits Rhesus macaque monkeys

    Guinea pigs and rabbits

  • 90

    Agglutination with yellow anti-serum, no agglutination with blue anti-serum : * 1/1 A + B + A B

    B

  • 91

    Reported the use of sodium citrate as an anticoagulant solutions for transfusions in 1914: * 1/1 Edward Lindemann Hustin Lewisohn Rous and Turner

    Hustin

  • 92

    Introduced citrate-dextrose solution for preservation of blood in 1916: * 1/1 Edward Lindemann Hustin Lewisohn Rous and Turner

    Rous and Turner

  • 93

    Prospective donors with a history of SYPHILIS or GONORRHEA, of treatment for either, or of a reactive screening test for syphilis, or where no confirmatory test was performed, should be deferred for ___months AFTER COMPLETION OF THERAPY. * 1/1 3 months 6 months 12 months 36 months

    12 months

  • 94

    Donor deferral after complete recovery from tuberculosis: * 0/1 3 months 6 months 12 months 24 months

    24 months

  • 95

    For ABO grouping, mix red cell suspension and antiserum and centrifuge for approximately: * 0/1 10 seconds 15 seconds 20 seconds 60 seconds

    20 seconds

  • 96

    Centrifugation for the GEL TEST: * 1/1 5 minutes 10 minutes 15 minutes 20 minutes

    10 minutes

  • 97

    Shelf-life of FFP stored at -18C: * 0/1 24 hours 1 year 2 years 7 years 10 years

    1 year

  • 98

    Shelf-life of FFP stored at -65C: * 0/1 24 hours 1 year 2 years 7 years 10 years

    7 years

  • 99

    Fresh frozen plasma must be thawed at which temperature? * 1/1 1 to 6C Room temperature 37C 40C or higher

    37C

  • 100

    Once thawed, FFP must be transfused within: * 0/1 4 hours 6 hours 12 hours 24 hours

    24 hours

  • other names parasitology

    other names parasitology

    Yves Laure Pimentel · 70問 · 2年前

    other names parasitology

    other names parasitology

    70問 • 2年前
    Yves Laure Pimentel

    PARASITOLOGY

    PARASITOLOGY

    Yves Laure Pimentel · 111問 · 2年前

    PARASITOLOGY

    PARASITOLOGY

    111問 • 2年前
    Yves Laure Pimentel

    HTMLBE

    HTMLBE

    Yves Laure Pimentel · 64問 · 2年前

    HTMLBE

    HTMLBE

    64問 • 2年前
    Yves Laure Pimentel

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    Yves Laure Pimentel · 61問 · 2年前

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    61問 • 2年前
    Yves Laure Pimentel

    HISTOPATHOLOGY

    HISTOPATHOLOGY

    Yves Laure Pimentel · 69問 · 2年前

    HISTOPATHOLOGY

    HISTOPATHOLOGY

    69問 • 2年前
    Yves Laure Pimentel

    CC-2 SPECTROPHOTOMETRY

    CC-2 SPECTROPHOTOMETRY

    Yves Laure Pimentel · 100問 · 2年前

    CC-2 SPECTROPHOTOMETRY

    CC-2 SPECTROPHOTOMETRY

    100問 • 2年前
    Yves Laure Pimentel

    CC-3 ELECTROPHORESIS

    CC-3 ELECTROPHORESIS

    Yves Laure Pimentel · 41問 · 2年前

    CC-3 ELECTROPHORESIS

    CC-3 ELECTROPHORESIS

    41問 • 2年前
    Yves Laure Pimentel

    AUBF LAB SAFETY

    AUBF LAB SAFETY

    Yves Laure Pimentel · 87問 · 2年前

    AUBF LAB SAFETY

    AUBF LAB SAFETY

    87問 • 2年前
    Yves Laure Pimentel

    CSF 1

    CSF 1

    Yves Laure Pimentel · 100問 · 2年前

    CSF 1

    CSF 1

    100問 • 2年前
    Yves Laure Pimentel

    CSF 2

    CSF 2

    Yves Laure Pimentel · 82問 · 2年前

    CSF 2

    CSF 2

    82問 • 2年前
    Yves Laure Pimentel

    SEMEN 1

    SEMEN 1

    Yves Laure Pimentel · 100問 · 2年前

    SEMEN 1

    SEMEN 1

    100問 • 2年前
    Yves Laure Pimentel

    SEMEN 2

    SEMEN 2

    Yves Laure Pimentel · 7問 · 2年前

    SEMEN 2

    SEMEN 2

    7問 • 2年前
    Yves Laure Pimentel

    SYNOVIAL FLUID 1

    SYNOVIAL FLUID 1

    Yves Laure Pimentel · 100問 · 2年前

    SYNOVIAL FLUID 1

    SYNOVIAL FLUID 1

    100問 • 2年前
    Yves Laure Pimentel

    SYNOVIAL FLUID 2

    SYNOVIAL FLUID 2

    Yves Laure Pimentel · 6問 · 2年前

    SYNOVIAL FLUID 2

    SYNOVIAL FLUID 2

    6問 • 2年前
    Yves Laure Pimentel

    SEROUS FLUID

    SEROUS FLUID

    Yves Laure Pimentel · 25問 · 2年前

    SEROUS FLUID

    SEROUS FLUID

    25問 • 2年前
    Yves Laure Pimentel

    PLEURAL FLUID

    PLEURAL FLUID

    Yves Laure Pimentel · 44問 · 2年前

    PLEURAL FLUID

    PLEURAL FLUID

    44問 • 2年前
    Yves Laure Pimentel

    PERICARDIAL FLUID

    PERICARDIAL FLUID

    Yves Laure Pimentel · 18問 · 2年前

    PERICARDIAL FLUID

    PERICARDIAL FLUID

    18問 • 2年前
    Yves Laure Pimentel

    PERITONEAL FLUID/ ASCITIC FLUID

    PERITONEAL FLUID/ ASCITIC FLUID

    Yves Laure Pimentel · 30問 · 2年前

    PERITONEAL FLUID/ ASCITIC FLUID

    PERITONEAL FLUID/ ASCITIC FLUID

    30問 • 2年前
    Yves Laure Pimentel

    AMNIOTIC FLUID

    AMNIOTIC FLUID

    Yves Laure Pimentel · 92問 · 2年前

    AMNIOTIC FLUID

    AMNIOTIC FLUID

    92問 • 2年前
    Yves Laure Pimentel

    FECALYSIS

    FECALYSIS

    Yves Laure Pimentel · 80問 · 2年前

    FECALYSIS

    FECALYSIS

    80問 • 2年前
    Yves Laure Pimentel

    OTHER BODY FLUIDS

    OTHER BODY FLUIDS

    Yves Laure Pimentel · 89問 · 2年前

    OTHER BODY FLUIDS

    OTHER BODY FLUIDS

    89問 • 2年前
    Yves Laure Pimentel

    MTLBE- SUHO NOTES

    MTLBE- SUHO NOTES

    Yves Laure Pimentel · 86問 · 2年前

    MTLBE- SUHO NOTES

    MTLBE- SUHO NOTES

    86問 • 2年前
    Yves Laure Pimentel

    MTLBE..

    MTLBE..

    Yves Laure Pimentel · 35問 · 2年前

    MTLBE..

    MTLBE..

    35問 • 2年前
    Yves Laure Pimentel

    CC- CHROMATOGRAPHY

    CC- CHROMATOGRAPHY

    Yves Laure Pimentel · 19問 · 1年前

    CC- CHROMATOGRAPHY

    CC- CHROMATOGRAPHY

    19問 • 1年前
    Yves Laure Pimentel

    CC-OSMOMETRY

    CC-OSMOMETRY

    Yves Laure Pimentel · 14問 · 1年前

    CC-OSMOMETRY

    CC-OSMOMETRY

    14問 • 1年前
    Yves Laure Pimentel

    CC-ELECTROCHEMISTRY TECHNIQUES

    CC-ELECTROCHEMISTRY TECHNIQUES

    Yves Laure Pimentel · 43問 · 1年前

    CC-ELECTROCHEMISTRY TECHNIQUES

    CC-ELECTROCHEMISTRY TECHNIQUES

    43問 • 1年前
    Yves Laure Pimentel

    CC- CARBOHYDRATES

    CC- CARBOHYDRATES

    Yves Laure Pimentel · 49問 · 2年前

    CC- CARBOHYDRATES

    CC- CARBOHYDRATES

    49問 • 2年前
    Yves Laure Pimentel

    CC- DIABETES MELLITUS

    CC- DIABETES MELLITUS

    Yves Laure Pimentel · 97問 · 2年前

    CC- DIABETES MELLITUS

    CC- DIABETES MELLITUS

    97問 • 2年前
    Yves Laure Pimentel

    MAJOR LIPOPROTEINS

    MAJOR LIPOPROTEINS

    Yves Laure Pimentel · 57問 · 2年前

    MAJOR LIPOPROTEINS

    MAJOR LIPOPROTEINS

    57問 • 2年前
    Yves Laure Pimentel

    MINOR LIPOPROTEINS

    MINOR LIPOPROTEINS

    Yves Laure Pimentel · 63問 · 2年前

    MINOR LIPOPROTEINS

    MINOR LIPOPROTEINS

    63問 • 2年前
    Yves Laure Pimentel

    PROTEINS

    PROTEINS

    Yves Laure Pimentel · 37問 · 2年前

    PROTEINS

    PROTEINS

    37問 • 2年前
    Yves Laure Pimentel

    PLASMA PROTEINS 1

    PLASMA PROTEINS 1

    Yves Laure Pimentel · 91問 · 2年前

    PLASMA PROTEINS 1

    PLASMA PROTEINS 1

    91問 • 2年前
    Yves Laure Pimentel

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    Yves Laure Pimentel · 98問 · 2年前

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    98問 • 2年前
    Yves Laure Pimentel

    MISCELLANEOUS PROTEINS

    MISCELLANEOUS PROTEINS

    Yves Laure Pimentel · 61問 · 2年前

    MISCELLANEOUS PROTEINS

    MISCELLANEOUS PROTEINS

    61問 • 2年前
    Yves Laure Pimentel

    Liver Function Test 1

    Liver Function Test 1

    Yves Laure Pimentel · 100問 · 2年前

    Liver Function Test 1

    Liver Function Test 1

    100問 • 2年前
    Yves Laure Pimentel

    Liver Function Test 2

    Liver Function Test 2

    Yves Laure Pimentel · 96問 · 2年前

    Liver Function Test 2

    Liver Function Test 2

    96問 • 2年前
    Yves Laure Pimentel

    TUMOR MARKERS

    TUMOR MARKERS

    Yves Laure Pimentel · 33問 · 2年前

    TUMOR MARKERS

    TUMOR MARKERS

    33問 • 2年前
    Yves Laure Pimentel

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    Yves Laure Pimentel · 41問 · 2年前

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    41問 • 2年前
    Yves Laure Pimentel

    GLYCOGEN STORAGE DISEASES

    GLYCOGEN STORAGE DISEASES

    Yves Laure Pimentel · 17問 · 2年前

    GLYCOGEN STORAGE DISEASES

    GLYCOGEN STORAGE DISEASES

    17問 • 2年前
    Yves Laure Pimentel

    LIPID STORAGE DISEASES

    LIPID STORAGE DISEASES

    Yves Laure Pimentel · 14問 · 2年前

    LIPID STORAGE DISEASES

    LIPID STORAGE DISEASES

    14問 • 2年前
    Yves Laure Pimentel

    PROTEINS

    PROTEINS

    Yves Laure Pimentel · 71問 · 2年前

    PROTEINS

    PROTEINS

    71問 • 2年前
    Yves Laure Pimentel

    QUICK FIRE- ELECTRODES

    QUICK FIRE- ELECTRODES

    Yves Laure Pimentel · 7問 · 2年前

    QUICK FIRE- ELECTRODES

    QUICK FIRE- ELECTRODES

    7問 • 2年前
    Yves Laure Pimentel

    ELECTROLYTES

    ELECTROLYTES

    Yves Laure Pimentel · 10問 · 2年前

    ELECTROLYTES

    ELECTROLYTES

    10問 • 2年前
    Yves Laure Pimentel

    DRUGS

    DRUGS

    Yves Laure Pimentel · 27問 · 2年前

    DRUGS

    DRUGS

    27問 • 2年前
    Yves Laure Pimentel

    TOXIC AGENTS:

    TOXIC AGENTS:

    Yves Laure Pimentel · 12問 · 2年前

    TOXIC AGENTS:

    TOXIC AGENTS:

    12問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    Yves Laure Pimentel · 100問 · 2年前

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    100問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY (HEMATOPOIESIS 2)

    HEMATOLOGY (HEMATOPOIESIS 2)

    Yves Laure Pimentel · 29問 · 2年前

    HEMATOLOGY (HEMATOPOIESIS 2)

    HEMATOLOGY (HEMATOPOIESIS 2)

    29問 • 2年前
    Yves Laure Pimentel

    hema diseases

    hema diseases

    Yves Laure Pimentel · 25問 · 2年前

    hema diseases

    hema diseases

    25問 • 2年前
    Yves Laure Pimentel

    AML

    AML

    Yves Laure Pimentel · 43問 · 2年前

    AML

    AML

    43問 • 2年前
    Yves Laure Pimentel

    GLOBIN SYNTHESIS

    GLOBIN SYNTHESIS

    Yves Laure Pimentel · 71問 · 2年前

    GLOBIN SYNTHESIS

    GLOBIN SYNTHESIS

    71問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY REFERENCE RANGES

    HEMATOLOGY REFERENCE RANGES

    Yves Laure Pimentel · 31問 · 2年前

    HEMATOLOGY REFERENCE RANGES

    HEMATOLOGY REFERENCE RANGES

    31問 • 2年前
    Yves Laure Pimentel

    DISORDERS OF PRIMARY HEMOSTASIS

    DISORDERS OF PRIMARY HEMOSTASIS

    Yves Laure Pimentel · 34問 · 2年前

    DISORDERS OF PRIMARY HEMOSTASIS

    DISORDERS OF PRIMARY HEMOSTASIS

    34問 • 2年前
    Yves Laure Pimentel

    PLATELET DISORDERS

    PLATELET DISORDERS

    Yves Laure Pimentel · 37問 · 2年前

    PLATELET DISORDERS

    PLATELET DISORDERS

    37問 • 2年前
    Yves Laure Pimentel

    CHARACTERISTICS OF CLOTTING FACTORS

    CHARACTERISTICS OF CLOTTING FACTORS

    Yves Laure Pimentel · 100問 · 2年前

    CHARACTERISTICS OF CLOTTING FACTORS

    CHARACTERISTICS OF CLOTTING FACTORS

    100問 • 2年前
    Yves Laure Pimentel

    4. CLASSIFICATION OF MACROPHAGE

    4. CLASSIFICATION OF MACROPHAGE

    Yves Laure Pimentel · 12問 · 2年前

    4. CLASSIFICATION OF MACROPHAGE

    4. CLASSIFICATION OF MACROPHAGE

    12問 • 2年前
    Yves Laure Pimentel

    3. NATURAL OR INNATE IMMUNITY

    3. NATURAL OR INNATE IMMUNITY

    Yves Laure Pimentel · 39問 · 2年前

    3. NATURAL OR INNATE IMMUNITY

    3. NATURAL OR INNATE IMMUNITY

    39問 • 2年前
    Yves Laure Pimentel

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    Yves Laure Pimentel · 55問 · 2年前

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    55問 • 2年前
    Yves Laure Pimentel

    6. PHAGOCYTOSIS Chemotaxis

    6. PHAGOCYTOSIS Chemotaxis

    Yves Laure Pimentel · 37問 · 2年前

    6. PHAGOCYTOSIS Chemotaxis

    6. PHAGOCYTOSIS Chemotaxis

    37問 • 2年前
    Yves Laure Pimentel

    8. NATURE OF ANTIGEN

    8. NATURE OF ANTIGEN

    Yves Laure Pimentel · 44問 · 2年前

    8. NATURE OF ANTIGEN

    8. NATURE OF ANTIGEN

    44問 • 2年前
    Yves Laure Pimentel

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    Yves Laure Pimentel · 50問 · 2年前

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    50問 • 2年前
    Yves Laure Pimentel

    1. HISTORY

    1. HISTORY

    Yves Laure Pimentel · 69問 · 2年前

    1. HISTORY

    1. HISTORY

    69問 • 2年前
    Yves Laure Pimentel

    2. TYPES OF IMMUNITY

    2. TYPES OF IMMUNITY

    Yves Laure Pimentel · 38問 · 2年前

    2. TYPES OF IMMUNITY

    2. TYPES OF IMMUNITY

    38問 • 2年前
    Yves Laure Pimentel

    7. PHAGOCYTOSIS Engulfment and Digestion

    7. PHAGOCYTOSIS Engulfment and Digestion

    Yves Laure Pimentel · 21問 · 2年前

    7. PHAGOCYTOSIS Engulfment and Digestion

    7. PHAGOCYTOSIS Engulfment and Digestion

    21問 • 2年前
    Yves Laure Pimentel

    8. PHAGOCYTOSIS EXOCYTOSIS

    8. PHAGOCYTOSIS EXOCYTOSIS

    Yves Laure Pimentel · 15問 · 2年前

    8. PHAGOCYTOSIS EXOCYTOSIS

    8. PHAGOCYTOSIS EXOCYTOSIS

    15問 • 2年前
    Yves Laure Pimentel

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    Yves Laure Pimentel · 32問 · 2年前

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    32問 • 2年前
    Yves Laure Pimentel

    11. TRANSPLANTATION IMMUNOLOGY

    11. TRANSPLANTATION IMMUNOLOGY

    Yves Laure Pimentel · 30問 · 2年前

    11. TRANSPLANTATION IMMUNOLOGY

    11. TRANSPLANTATION IMMUNOLOGY

    30問 • 2年前
    Yves Laure Pimentel

    2. LYMPHOID ORGANS

    2. LYMPHOID ORGANS

    Yves Laure Pimentel · 38問 · 2年前

    2. LYMPHOID ORGANS

    2. LYMPHOID ORGANS

    38問 • 2年前
    Yves Laure Pimentel

    3. CLUSTER OF DIFFERENTIATION

    3. CLUSTER OF DIFFERENTIATION

    Yves Laure Pimentel · 48問 · 2年前

    3. CLUSTER OF DIFFERENTIATION

    3. CLUSTER OF DIFFERENTIATION

    48問 • 2年前
    Yves Laure Pimentel

    4. T-CELL DIFFERENTIATION

    4. T-CELL DIFFERENTIATION

    Yves Laure Pimentel · 35問 · 2年前

    4. T-CELL DIFFERENTIATION

    4. T-CELL DIFFERENTIATION

    35問 • 2年前
    Yves Laure Pimentel

    5. T CELL IMMUNODEFICIENCIES

    5. T CELL IMMUNODEFICIENCIES

    Yves Laure Pimentel · 18問 · 2年前

    5. T CELL IMMUNODEFICIENCIES

    5. T CELL IMMUNODEFICIENCIES

    18問 • 2年前
    Yves Laure Pimentel

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    Yves Laure Pimentel · 44問 · 2年前

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    44問 • 2年前
    Yves Laure Pimentel

    7. B CELL IMMUNODEFICIENCIES

    7. B CELL IMMUNODEFICIENCIES

    Yves Laure Pimentel · 23問 · 2年前

    7. B CELL IMMUNODEFICIENCIES

    7. B CELL IMMUNODEFICIENCIES

    23問 • 2年前
    Yves Laure Pimentel

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    Yves Laure Pimentel · 34問 · 2年前

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    34問 • 2年前
    Yves Laure Pimentel

    9. COMPARISON OF T AND B CELLS

    9. COMPARISON OF T AND B CELLS

    Yves Laure Pimentel · 12問 · 2年前

    9. COMPARISON OF T AND B CELLS

    9. COMPARISON OF T AND B CELLS

    12問 • 2年前
    Yves Laure Pimentel

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    Yves Laure Pimentel · 16問 · 2年前

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    16問 • 2年前
    Yves Laure Pimentel

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    Yves Laure Pimentel · 15問 · 2年前

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    15問 • 2年前
    Yves Laure Pimentel

    12. ANTIBODY

    12. ANTIBODY

    Yves Laure Pimentel · 79問 · 2年前

    12. ANTIBODY

    12. ANTIBODY

    79問 • 2年前
    Yves Laure Pimentel

    13. TYPES OF ANTIBODIES

    13. TYPES OF ANTIBODIES

    Yves Laure Pimentel · 97問 · 2年前

    13. TYPES OF ANTIBODIES

    13. TYPES OF ANTIBODIES

    97問 • 2年前
    Yves Laure Pimentel

    14. MONOCLONAL ANTIBODIES

    14. MONOCLONAL ANTIBODIES

    Yves Laure Pimentel · 11問 · 2年前

    14. MONOCLONAL ANTIBODIES

    14. MONOCLONAL ANTIBODIES

    11問 • 2年前
    Yves Laure Pimentel

    1. INTERLEUKINS

    1. INTERLEUKINS

    Yves Laure Pimentel · 23問 · 2年前

    1. INTERLEUKINS

    1. INTERLEUKINS

    23問 • 2年前
    Yves Laure Pimentel

    2. INTERFERONS

    2. INTERFERONS

    Yves Laure Pimentel · 28問 · 2年前

    2. INTERFERONS

    2. INTERFERONS

    28問 • 2年前
    Yves Laure Pimentel

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    Yves Laure Pimentel · 8問 · 2年前

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    8問 • 2年前
    Yves Laure Pimentel

    4. COMPLEMENT SYSTEM

    4. COMPLEMENT SYSTEM

    Yves Laure Pimentel · 19問 · 2年前

    4. COMPLEMENT SYSTEM

    4. COMPLEMENT SYSTEM

    19問 • 2年前
    Yves Laure Pimentel

    15. COMPLEMENT SYSTEM

    15. COMPLEMENT SYSTEM

    Yves Laure Pimentel · 76問 · 2年前

    15. COMPLEMENT SYSTEM

    15. COMPLEMENT SYSTEM

    76問 • 2年前
    Yves Laure Pimentel

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    Yves Laure Pimentel · 21問 · 2年前

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    21問 • 2年前
    Yves Laure Pimentel

    17. COMPLEMENT AND DISEASE STATES

    17. COMPLEMENT AND DISEASE STATES

    Yves Laure Pimentel · 29問 · 2年前

    17. COMPLEMENT AND DISEASE STATES

    17. COMPLEMENT AND DISEASE STATES

    29問 • 2年前
    Yves Laure Pimentel

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    Yves Laure Pimentel · 19問 · 2年前

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    19問 • 2年前
    Yves Laure Pimentel

    19. CYTOKINES

    19. CYTOKINES

    Yves Laure Pimentel · 22問 · 2年前

    19. CYTOKINES

    19. CYTOKINES

    22問 • 2年前
    Yves Laure Pimentel

    20. INTERLEUKINS

    20. INTERLEUKINS

    Yves Laure Pimentel · 24問 · 2年前

    20. INTERLEUKINS

    20. INTERLEUKINS

    24問 • 2年前
    Yves Laure Pimentel

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    Yves Laure Pimentel · 21問 · 2年前

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21問 • 2年前
    Yves Laure Pimentel

    1. SERO

    1. SERO

    Yves Laure Pimentel · 54問 · 2年前

    1. SERO

    1. SERO

    54問 • 2年前
    Yves Laure Pimentel

    2. PRECIPITATION

    2. PRECIPITATION

    Yves Laure Pimentel · 38問 · 2年前

    2. PRECIPITATION

    2. PRECIPITATION

    38問 • 2年前
    Yves Laure Pimentel

    3. PASSIVE IMMUNODIFFUSION

    3. PASSIVE IMMUNODIFFUSION

    Yves Laure Pimentel · 17問 · 2年前

    3. PASSIVE IMMUNODIFFUSION

    3. PASSIVE IMMUNODIFFUSION

    17問 • 2年前
    Yves Laure Pimentel

    4. OUCHTERLONY

    4. OUCHTERLONY

    Yves Laure Pimentel · 15問 · 2年前

    4. OUCHTERLONY

    4. OUCHTERLONY

    15問 • 2年前
    Yves Laure Pimentel

    5. ELECTROPHORETIC TECHNIQUE

    5. ELECTROPHORETIC TECHNIQUE

    Yves Laure Pimentel · 9問 · 2年前

    5. ELECTROPHORETIC TECHNIQUE

    5. ELECTROPHORETIC TECHNIQUE

    9問 • 2年前
    Yves Laure Pimentel

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    Yves Laure Pimentel · 11問 · 2年前

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    11問 • 2年前
    Yves Laure Pimentel

    7. IMMUNOFIXATION ELECTROPHORESIS

    7. IMMUNOFIXATION ELECTROPHORESIS

    Yves Laure Pimentel · 29問 · 2年前

    7. IMMUNOFIXATION ELECTROPHORESIS

    7. IMMUNOFIXATION ELECTROPHORESIS

    29問 • 2年前
    Yves Laure Pimentel

    問題一覧

  • 1

    Transfusion-transmissible infectious agents for which UNIVERSAL SCREENING of all donations in all countries is recommended. Check four (4) boxes.

    Human immunodeficiency virus (HIV), Hepatitis B virus (HBV), Hepatitis C virus (HCV), Treponema pallidum (syphilis)

  • 2

    What is the maximum volume of blood that can be collected from a 110-lb donor, including samples for processing? * 0/1 450 mL 500 mL 525 mL 550 mL

    525 mL

  • 3

    When RBCs are stored, there is a “shift to the left.” This means: * 1/1 Hemoglobin-oxygen affinity increases, owing to an increase in 2,3 -DPG Hemoglobin-oxygen affinity increases, owing to a decrease in 2,3-DPG Hemoglobin-oxygen affinity decreases, owing to a decrease in 2,3-DPG Hemoglobin-oxygen affinity decreases, owing to an increase in 2,3-DPG

    Hemoglobin-oxygen affinity increases, owing to a decrease in 2,3-DPG

  • 4

    What are the current storage time and storage temperature for platelet concentrates and apheresis platelet components? * 1/1 5 days at 1°C to 6°C 5 days at 24°C to 27°C 5 days at 20°C to 24°C 7 days at 22°C to 24°C

    5 days at 20°C to 24°C

  • 5

    Prestorage pooled platelets can be stored for: * 0/1 4 hours 24 hours 5 days 7 days

    5 days

  • 6

    Additive solutions are approved for storage of red blood cells for how many days? * 0/1 21 42 35 7

    42

  • 7

    One criterion used by the FDA for approval of new preservation solutions and storage containers is an average 24-hour post-transfusion RBC survival of more than: * 1/1 50% 60% 65% 75%

    75%

  • 8

    What is the lowest allowable pH for a platelet component at outdate? * 1/1 6 5.9 6.8 6.2

    6.2

  • 9

    Which of the following occurs during storage of red blood cells? * 0/1 pH decreases 2,3-DPG increases ATP increases Plasma K+ decreases

    pH decreases

  • 10

    Which of the following is approved for bacterial detection specific to extending the expiration of apheresed platelets to 7 days? * 1/1 BacT/ALERT eBDS Gram stain Pan Genera Detection (PGD) test

    Pan Genera Detection (PGD) test

  • 11

    The pattern of inheritance most commonly expressed by blood group genes is: * 1/1 X-linked recessive Autosomal recessive Autosomal codominant X-linked codominant

    Autosomal codominant

  • 12

    RBCs must be washed in saline at least three times before the addition of AHG reagent to: * 0/1 Wash away any hemolyzed cells Remove traces of free serum globulins Neutralize any excess AHG reagent Increase the antibody binding to antigen

    Remove traces of free serum globulins

  • 13

    You are working on a specimen in the laboratory that you believe to be a Bombay phenotype. Which of the following reactions would you expect to see? * 0/1 Patient’s cells + Ulex europaeus = no agglutination Patient’s cells + Ulex europaeus = agglutination Patient’s serum + group O donor RBCs = no agglutination Patient’s serum + A1 and B cells = no agglutination

    Patient’s cells + Ulex europaeus = no agglutination

  • 14

    Which of the following ABO blood groups contains the least amount of H substance? * 1/1 A1B A2 B O

    A1B

  • 15

    Cells carrying a weak D antigen require the use of what test to demonstrate its presence? * 0/1 Indirect antiglobulin test Direct antiglobulin test Microplate test Warm autoadsorption test

    Indirect antiglobulin test

  • 16

    Which of the following is the most common haplotype in the African American population? * 1/1 DCe DcE Dce ce

    Dce

  • 17

    If a patient who is R1R1 is transfused with RBCs that are R0r, which antibody is he most likely to produce? * 0/1 Anti-D Anti-c Anti-e Anti-G

    Anti-c

  • 18

    The following results were obtained on a 51-year-old male with hepatitis C: * 0/1 Retype the patient’s sample to confirm group AB positive Repeat the Rh typing Run a saline control in forward grouping Report the patient as group AB, Rh positive

    Run a saline control in forward grouping

  • 19

    What is the purpose of including a reagent control when interpreting group AB, D-positive red cells after testing with a low-protein anti-D reagent? * 0/1 To detect false-positive agglutination reactions To detect false-negative agglutination reactions To identify a mix up with patient’s sample To confirm ABO typing results

    To detect false-positive agglutination reactions

  • 20

    Transformation to Leb phenotype after birth may be as follows: * 1/1 Le(a–b–) to Le(a+b–) to Le(a+b+) to Le(a–b+) Le(a+b–) to Le(a–b–) to Le(a–b+) to Le(a+b+) Le(a–b+) to Le(a+b–) to Le(a+b+) to Le(a–b–) Le(a+b+) to Le(a+b–) to Le(a–b–) to Le(a–b+)

    Le(a–b–) to Le(a+b–) to Le(a+b+) to Le(a–b+)

  • 21

    In what way do the Lewis antigens change during pregnancy? * 0/1 Lea antigen increases only Leb antigen increases only Lea and Leb both increase Lea and Leb both decrease

    Lea and Leb both decrease

  • 22

    The most commonly encountered of the Lewis antibodies: * 0/1 Anti-Le a Anti-Le b Anti-Le bH Anti-Le bL

    Anti-Le a

  • 23

    Which of the following best describes MN antigens and antibodies? * 1/1 Well developed at birth, susceptible to enzymes, generally saline reactive Not well developed at birth, susceptible to enzymes, generally saline reactive Well developed at birth, not susceptible to enzymes, generally saline reactive Well developed at birth, susceptible to enzymes, generally antiglobulin reactive

    Well developed at birth, susceptible to enzymes, generally saline reactive

  • 24

    Which autoantibody specificity is found in patients with paroxysmal cold hemoglobinuria? * 1/1 Anti-I Anti-i Anti-P Anti-P1

    Anti-P

  • 25

    Which of the following is the most common antibody seen in the blood bank after ABO and Rh antibodies? * 0/1 Anti-Fya Anti-k Anti-Jsa Anti-K

    Anti-K

  • 26

    Which antibody is most commonly associated with delayed hemolytic transfusion reactions? * 1/1 Anti-s Anti-k Anti-Lu Anti-Jk

    Anti-Jk

  • 27

    A patient with an M. pneumoniae infection will most likely develop a cold autoantibody with specificity to which antigen? * 0/1 I i P P1

    I

  • 28

    The antibody to this high-prevalence antigen demonstrates mixed-field agglutination that appears shiny and refractile under the microscope. * 0/1 Vel JMH Jr Sd

    Sd

  • 29

    What red blood cell treatment can be used to differentiate between anti-D and anti-LW? * 0/1 Ficin Trypsin Dithiothreitol (DTT) Papain

    Dithiothreitol (DTT)

  • 30

    A weakly reactive antibody with a titer of 128 is neutralized by plasma. Which of the following could be the specificity? * 1/1 Anti-JMH Anti-Ch Anti-Kn Anti-Kp

    Anti-Ch

  • 31

    The prevalence of ____ in Northern Europeans is 1% but is higher in the Mennonite population * 1/1 Diego a Diego b Scianna 1 Scianna 2

    Scianna 2

  • 32

    Anti-Sda has been identified in a patient. What substance would neutralize this antibody and allow detection of other alloantibodies? * 0/1 Saliva Hydatid cyst fluid Urine Human breast milk

    Urine

  • 33

    How many days before a pretransfusion specimen expires? * 1/1 3 days 7 days 14 days 1 month

    3 days

  • 34

    How many days must a pretransfusion specimen and donor unit segments be retained post-transfusion? * 0/1 3 days 7 days 14 days 1 month

    7 days

  • 35

    Which is not true of rouleaux formation? * 1/1 Mimics agglutination Appears like a “stacking of coins” Can be seen in the antiglobulin test Can be dispersed by saline

    Can be seen in the antiglobulin test

  • 36

    Protein A captures antibodies by binding to the: * 1/1 Fab portion of immunoglobulin Fc portion of immunoglobulin Surface of test cells Surface of indicator cells

    Fc portion of immunoglobulin

  • 37

    Immunization for rubella (German measles) would result in a temporary deferral for: * 1/1 4 weeks 2 weeks 1 year 3 years

    4 weeks

  • 38

    Which of the following carries a 12-month deferral? * 1/1 Donor received Hepatitis B immune globulin Donor received pituitary growth hormone from another human Donor received the MMR vaccine Donor spent 10 years in Africa

    Donor received Hepatitis B immune globulin

  • 39

    A first-trimester or second trimester abortion or miscarriage: * 1/1 4 weeks deferral 6 weeks deferral 12 months deferral Not cause for deferral

    Not cause for deferral

  • 40

    Donors who have received a transfusion of blood or its components or other human tissues (organ, tissue, bone marrow transplant, or bone or skin graft) known to be possible sources of bloodborne pathogens should be deferred for _____ from the time of receiving the blood product or graft * 0/1 4 weeks 6 weeks 12 months 3 years

    12 months

  • 41

    Currently, steps taken to reduce transfusion-transmitted CMV include: * 1/1 Plaque reduction neutralization test NAT testing Leukoreduction Minipool screening

    Leukoreduction

  • 42

    The first retrovirus to be associated with human disease was: * 1/1 HCV HIV-1 HTLV-1 WNV

    HTLV-1

  • 43

    What is the most common parasitic complication of transfusion? * 1/1 Babesia microti Trypanosoma cruzi Plasmodium species Toxoplasma gondii

    Plasmodium species

  • 44

    RBCs that have been leukoreduced must contain less than ______ leukocytes and retain at least ______ of original RBCs. * 1/1 8 × 10 6th/ 85% 8 × 10 6th/ 90% 5 × 10 6th/ 85% 5 × 10 6th / 80%

    5 × 10 6th/ 85%

  • 45

    Patient with APLASTIC ANEMIA should be transfused with: * 0/1 Fresh whole blood (FWB) Washed RBCs less than 7 days old Fresh frozen plasma and platelets Cryoprecipitated AHF

    Washed RBCs less than 7 days old

  • 46

    Leukocyte-reduced filters can do all of the following except: * 1/1 Reduce the risk of CMV infection Prevent or reduce the risk of HLA alloimmunization Prevent febrile, nonhemolytic transfusion reactions Prevent TA-GVHD

    Prevent TA-GVHD

  • 47

    Which patient does NOT need an irradiated component? * 0/1 Bone marrow transplant recipient Neonate weighing less than 1,200 g Adult receiving an RBC transfusion Adult receiving an RBC transfusion from a blood relative

    Adult receiving an RBC transfusion

  • 48

    RBC transfusions should be given: * 1/1 Within 4 hours With lactated Ringer solution With dextrose and water With cryoprecipitate

    Within 4 hours

  • 49

    Which type of transplantation requires all cellular blood components to be irradiated? * 1/1 Bone marrow Heart Liver Kidney

    Bone marrow

  • 50

    Select the appropriate product for a bone marrow transplant patient with anemia: * 1/1 RBCs Irradiated RBCs Leukoreduced RBCs Washed RBCs

    Irradiated RBCs

  • 51

    Which fluid should be used to dilute RBCs? * 0/1 0.9% saline 5% dextrose and water Immune globulin Lactated Ringer solution

    0.9% saline

  • 52

    Fatal transfusion reactions are mostly caused by: * 1/1 Serologic errors Improper storage of blood Improper handling of the product Clerical errors

    Clerical errors

  • 53

    Pain at infusion site and hypotension are observed with what type of reaction? * 0/1 Delayed hemolytic transfusion reaction Acute hemolytic transfusion reaction Allergic reaction Febrile nonhemolytic reaction

    Acute hemolytic transfusion reaction

  • 54

    The most common isolate found in RBC units: * 1/1 Bacillus cereus Propionobacterium acnes Staphylococcus epidermidis Yersinia enterocolitica

    Yersinia enterocolitica

  • 55

    The organisms most frequently recovered from donated blood and contamination of platelets: * 0/1 Yersinia enterocolitica and Pseudomonas species Yersinia enterocolitica and Propionobacterium acnes Staphylococcus aureus and Bacillus cereus Staphylococcus epidermidis and Bacilus cereus

    Staphylococcus epidermidis and Bacilus cereus

  • 56

    The only presenting sign most often accompanying a delayed hemolytic transfusion reaction is: * 0/2 Renal failure Unexplained decrease in hemoglobin Active bleeding Hives

    Unexplained decrease in hemoglobin

  • 57

    Which transfusion reaction presents with fever, maculopapular rash, watery diarrhea, abnormal liver function, and pancytopenia? * 1/1 Transfusion-associated sepsis Transfusion-related acute lung injury Transfusion-associated graft-versus-host disease Transfusion-associated allergic reaction

    Transfusion-associated graft-versus-host disease

  • 58

    The most common anticoagulant used for apheresis procedures is: * 0/1 Heparin Sodium fluoride Warfarin Citrate

    Citrate

  • 59

    The minimum interval allowed between plateletpheresis component collection procedures is: * 1/1 1 day 2 days 7 days 8 weeks

    2 days

  • 60

    Which of the following can be given to an apheresis donor to increase the number of circulating granulocytes? * 1/1 DDAVP Hydroxyethyl starch (HES) Immune globulin G-CSF

    G-CSF

  • 61

    Acute transfusion reactions: signs or symptoms presenting during or within ___ hours of transfusion * 0/1 Within 4 hours Within 24 hours Within 48 hours Within 72 hours

    Within 24 hours

  • 62

    In humans, there are ____ chromosomes. * 1/1 2 chromosomes (1 pair) 22 chromosomes (11 pairs) 44 chromosomes (22 pairs) 46 chromosomes (23 pairs)

    46 chromosomes (23 pairs)

  • 63

    Humans have ___ autosomes and ____ of sex chromosomes, * 0/1 1 pair of autosomes, 23 pairs sex chromosomes 22 pairs of autosomes, 2 pairs sex chromosomes 22 pairs of autosomes, 1 pair sex chromosomes 23 pairs of autosomes, 1 pair sex chromosomes

    22 pairs of autosomes, 1 pair sex chromosomes

  • 64

    A1 individuals: * 0/1 A antigen A and A1 antigens Anti-A2 Production of only 240,000 to 290,000 antigen sites on the adult RBCs

    A and A1 antigens

  • 65

    The ultimate goal of biological safety is to: * 0/1 Provide safe and sterile working area Provide immunity to healthcare workers Prevent completion of the chain of infection by preventing transmission Prevent the spread of harmful aerosols

    Prevent completion of the chain of infection by preventing transmission

  • 66

    Which of the following includes an amorph? * 1/1 DcE DCE dce All of these

    dce

  • 67

    A cause of indefinite deferral of blood donation is: * 1/1 German measles vaccination Residence in an endemic malaria region Positive test for Trypanosoma cruzi History of therapeutic rabies vaccine

    Positive test for Trypanosoma cruzi

  • 68

    Which one of the following constitutes permanent deferral status of a donor? * 1/1 Tattoo 5 months previously Recent close contact with a patient with viral hepatitis 2 units of blood transfused 4 months previously Confirmed positive test for HBsAg 10 years previously

    Confirmed positive test for HBsAg 10 years previously

  • 69

    Which of the following donors may be accepted as a blood donor? * 0/1 Traveled to an area endemic for malaria 9 months previously Spontaneous abortion at 2 months, 3 months previously Resides with a known hepatitis B patient Received blood transfusion 22 weeks previously

    Spontaneous abortion at 2 months, 3 months previously

  • 70

    In order to be a plateletpheresies donor, the platelet count must be at least: * 1/1 150,000/uL 200,000/uL 250,000/uL 300,000/uL

    150,000/uL

  • 71

    Prior to blood donation, the intended venipuncture site must be cleaned with a scrub solution containing: * 1/1 Hypochlorite Green soap 10% acetone Povidone iodine

    Povidone iodine

  • 72

    What is/are the minimum pretransfusion testing requirement(s) for autologous donations collected and transfused by the same facility? * 0/1 ABO and Rh typing only ABO/Rh type and antibody screen ABO/Rh type, antibody screen, crossmatch No pretransfusion testing is required for autologous donation

    ABO and Rh typing only

  • 73

    Upon inspection, a unit of aphaeresis platelets is noted to have visible clots, but otherwise appears normal. The technologist should: 1/1 Issue without concern Filter to remove clots Centrifuge to express off the clots Quarantine for Gram stain and culture

    Quarantine for Gram stain and culture

  • 74

    An important determinant of platelet viability during storage is: * 1/1 Plasma potassium concentration Plasma pH Prothrombin time Partial thromboplastin time Feedback

    Plasma pH

  • 75

    term refers to the test results obtained with specific antisera,

    PHENOTYPE

  • 76

    refers to the genetic makeup of an individual.

    GENOTYPE

  • 77

    An individual's red blood cells give the following reactions with RH antisera: anti-D (4+), anti-C (3+), anti-E (neg), anti-c(3+) anti-e (3+). The individual's most probable GENOTYPE is: * 0/1 DCe/DcE DcE/dce Dce/dce DCe/dce

    DCe/dce

  • 78

    An individual's red blood cells give the following reactions with RH antisera: anti-D (4+), anti-C (3+), anti-E (neg), anti-c(3+) anti-e (3+). The individual's PHENOTYPE is: * 0/1 Dce/dce DCe/dce DCce Dce

    DCce

  • 79

    ABO hemolytic disease of the fetus and newborn (HDFN) differs from Rh HDFN in that: * 0/1 Rh HDFN is clinically more severe than ABO HDFN The direct antiglobulin test is weaker in Rh HDFN than ABO Rh HDFN occurs in the first pregnancy The mother's antibody screen is positive in ABO HDFN

    Rh HDFN is clinically more severe than ABO HDFN

  • 80

    RBCs agglutinated by Dolichos biflorus: * 1/1 O red cells B and AB red cells A2 and A2B red cells A1 and A1B red cells

    A1 and A1B red cells

  • 81

    Some blood group antibodies characteristically hemolyze appropriate antigen-positive red cells in the presence of : * 1/1 Complement Anticoagulants Preservatives Penicillin

    Complement

  • 82

    The major crossmatch will detect a(an): * 1/1 Group A patient mistyped as O Unexpected red cell antibody in the donor unit Rh-negative donor unit mislabeled as Rh-positive Recipient antibody directed against antigens on the donor red cells

    Recipient antibody directed against antigens on the donor red cells

  • 83

    In the Fisher-Race nomenclature, "d" represents: * 1/1 Presence of D antigen Absence of D antigen Elimination of D antigen Weak D antigen

    Absence of D antigen

  • 84

    If the Du rosette test is positive, quantitation of the fetomaternal hemorrhage must be done by: * 0/1 Spectrophotometric technique Indirect antiglobulin test Flow cytometry Hemagglutination-inhibition test

    Flow cytometry

  • 85

    Performed as early as 10 to 12 weeks’ gestation to determine whether the FETUS has the gene for the D antigen: * 1/1 Amniocentesis Cordocentesis Peripheral blood sample None of these

    Amniocentesis

  • 86

    Defined as the proportion of cases with a specific disease or condition that give a positive test result: * 0/1 Sensitivity Specificity

    Sensitivity

  • 87

    Defined as the proportion of cases with absence of the specific disease or condition that gives a negative test result: * 0/1 Sensitivity Specificity

    Specificity

  • 88

    How are Rh antigens inherited? * 1/1 Autosomal recessive alleles Sex-linked genes Codominant alleles X-linked

    Codominant alleles

  • 89

    Which animal was immunized that led to discovery of the Rh blood group? * 0/1 Mice Bats Guinea pigs and rabbits Rhesus macaque monkeys

    Guinea pigs and rabbits

  • 90

    Agglutination with yellow anti-serum, no agglutination with blue anti-serum : * 1/1 A + B + A B

    B

  • 91

    Reported the use of sodium citrate as an anticoagulant solutions for transfusions in 1914: * 1/1 Edward Lindemann Hustin Lewisohn Rous and Turner

    Hustin

  • 92

    Introduced citrate-dextrose solution for preservation of blood in 1916: * 1/1 Edward Lindemann Hustin Lewisohn Rous and Turner

    Rous and Turner

  • 93

    Prospective donors with a history of SYPHILIS or GONORRHEA, of treatment for either, or of a reactive screening test for syphilis, or where no confirmatory test was performed, should be deferred for ___months AFTER COMPLETION OF THERAPY. * 1/1 3 months 6 months 12 months 36 months

    12 months

  • 94

    Donor deferral after complete recovery from tuberculosis: * 0/1 3 months 6 months 12 months 24 months

    24 months

  • 95

    For ABO grouping, mix red cell suspension and antiserum and centrifuge for approximately: * 0/1 10 seconds 15 seconds 20 seconds 60 seconds

    20 seconds

  • 96

    Centrifugation for the GEL TEST: * 1/1 5 minutes 10 minutes 15 minutes 20 minutes

    10 minutes

  • 97

    Shelf-life of FFP stored at -18C: * 0/1 24 hours 1 year 2 years 7 years 10 years

    1 year

  • 98

    Shelf-life of FFP stored at -65C: * 0/1 24 hours 1 year 2 years 7 years 10 years

    7 years

  • 99

    Fresh frozen plasma must be thawed at which temperature? * 1/1 1 to 6C Room temperature 37C 40C or higher

    37C

  • 100

    Once thawed, FFP must be transfused within: * 0/1 4 hours 6 hours 12 hours 24 hours

    24 hours